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base polymer powders prior to processing. We demonstrate that the mechanical properties of the 
resultant composite parts are similar to standard polymer parts and reveal the mode of the antibacterial 
activity. We show that antibacterial activity is modulated by the presence of obstructing compounds 
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approach could be adopted more generally to add new functionality to Laser Sintered parts.
he global Additive Manufacturing (AM) market has grown by an average of 26.9% annually for the last 30 
years, with the overall revenue of the industry currently estimated at $9.8 billion, and aerospace, automotive and 
healthcare being major sectors1. Parts are produced in a layer-by-layer manner, directly from a Computer-Aided 
Design (CAD) ile. his layer-by-layer approach provides key beneits through removing the need for tooling 
and increasing the ease with which complex geometries can be produced. However, despite their clear potential, 
the range of materials that can be used in AM processes is limited compared to more traditional manufacturing 
techniques, which in turn has restricted the range of applications in which they can be used.
Laser Sintering is an AM technology that produces parts by selectively scanning and melting consecutive 
cross-sections of polymer powder particles. Areas which have not been scanned remain as loose powder through-
out the process, acting to support any overhanging areas, which in turn allows the economic production of highly 
complex part geometries. his geometric capability makes Laser Sintering highly suited to production of com-
plex, optimised, products and devices, or to the production of products and devices personalised to individuals. 
However, particularly when considering hand-held and/or medical products, increasing geometric complexity 
can render them diicult and time-consuming to clean efectively, potentially providing increased chance of 
spread of bacteria. Incorporation of antibacterial properties into the parts themselves could reduce or eliminate 
this risk, and is the focus of this work.
Many antimicrobial products are currently available to purchase, with a growing global market for antimi-
crobial additives (materials that are added to base materials to yield antimicrobial properties). Antimicrobial 
products are used in the healthcare sector as well as in consumer goods - the demand for these is driven not 
only by a desire to improve health, but to develop opportunities to create added value. hey have the potential 
to make a positive impact in healthcare in implants, prosthetics and splints2, and surfaces and devices in clinical 
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settings (e.g. sinks, instruments, keyboards). Adlhart and colleagues propose a helpful set of categories for anti-
microbial surfaces: anti-adhesive surfaces (based on preventing microbial attachment3), contact-active surfaces 
(that kill microbes on contact) or biocide releasing surfaces (from which the active ingredient is eluted into the 
surroundings)4. If a material is not inherently antimicrobial, the diferent types are obtained either by mixing 
antimicrobial additives into the bulk material, or through direct physical modiication (e.g. altered roughness) 
or chemical modiication (e.g. attachment of a biocide) to the surface. he biocidal properties of copper, zinc 
and silver (amongst other metals) are exploited in commercial antimicrobial additives and in ongoing research5, 
with silver a well-established choice. We therefore chose to develop a composite material to be used in AM using 
silver-based additives.
Research into AM of antimicrobial materials is a small but rapidly growing ield. Researchers have incor-
porated antimicrobials (or antibiotics) into polymer, metal and ceramic composites using a range of AM tech-
niques. Fused Deposition Modelling (FDM) has been used to incorporate, for example, nitrofurantoin6 or silver 
nitrate7 for potential use in medicine and healthcare. Stereolithography (SLA) has been used to incorporate 
4-aminosalicylic acid8 for customised drug-release kinetics, silver nanoparticles9 or quaternary ammonium 
compounds10. Binder Jetting has been employed, oten exploiting the capacity to dissolve antibiotics in the liq-
uid binder, to form polymer11 or ceramic12 composites, for potential bone implants amongst other applications. 
Robocasting has been used to incorporate a range of agents including levoloxacin13, quaternary ammonium 
compounds14 or silver nanoparticles15, in a ield again largely aimed at developing bone implants. Selective Laser 
Melting (SLM) of titanium16 or cobalt-chromium-molybdenum17 has been employed by several groups to develop 
bone implants – adding antimicrobial functionality to these generally requires a post-processing step, likely due 
to the high temperatures involved in melting metal being deleterious to many antimicrobials. To the best of our 
knowledge, no antimicrobial materials made using Laser Sintering have been described to date in the academic 
literature.
he proposed antimicrobial efects of silver remain an active research topic and fall into two broad categories: 
direct reactions between silver ions and cellular components (proteins, membranes, DNA) or indirect damage 
caused by reactive oxygen species (e.g. hydrogen peroxide) generated by the silver18,19. Xiu and coworkers showed 
that silver ions are equally toxic to Escherichia coli in aerobic and anaerobic conditions, contending on the basis 
of this that reactive oxygen has no role in the mechanism of action. However, an earlier study of E. coli and 
Staphylococcus aureus20 contradicts this inding, arguing that there is a role for oxidative stress under aerobic 
conditions. It may be that this inconsistency can explained by methodological diferences. An important study 
highlights the protective efect of thiol groups in the experimental medium21. It seems reasonable on the basis 
of this to assume that silver can bind these thiols and as a result become unavailable to participate in any other 
reactions that might (directly or indirectly) harm microbes. It has also been established that increased levels of 
serum in growth medium for cultured human cells is protective against the toxic efects of silver22, perhaps by a 
similar thiol-binding mechanism. Whatever the mechanism of antimicrobial action, our concern as engineers is 
to develop an approach that can safely kill or inhibit microbes using silver ions, and all relevant previous research 
suggests that to do this silver ions must be available in proximity to the microbes. In this manuscript, we do not 
contribute to the debate on the mechanism of action of silver as an antimicrobial, but explain how our material 
delivers silver ions and under what circumstances it will be most useful.
Here, we have adopted a commercially available antimicrobial additive (Biocote B65003) and combined this 
with a widely used Laser Sintering powder (polyamide 12, EOS PA2200) to create an antimicrobial material suit-
able for a range of potential uses. We characterise the resulting composite parts, including their mechanical prop-
erties, antibacterial properties (using S. aureus as a model Gram positive organism and Pseudomonas aeruginosa 
as a model Gram negative), and demonstrate a lack of cytotoxic efects.
Results and Discussion
Processability of material. We printed polyamide 12 parts in a range of geometries using standard settings 
for this material on a commercial EOS Formiga P100 printer. We subsequently printed the same part geome-
tries in polyamide 12 mixed with 1% B65003 silver phosphate glass. he parts were qualitatively near-identical 
(Fig. 1a). his straightforward experiment demonstrated the processability of a mix of sinterable and non-sinter-
able powders via a Laser Sintering 3D printer.
Mechanical properties of parts. Tensile testing was employed to ensure that there were no detrimental 
efects on the mechanical properties of the composite when compared with the standard polyamide 12 Laser 
Sintering material. We therefore printed “dogbones” for use in tensile testing, which involved measuring the 
force required to break the parts when subjected to a tensile load. his yielded measurements of Young’s Modulus 
(E – the stifness of the material), Ultimate Tensile Strength (σuts – how much force per unit area is needed to 
break the material) and Elongation at Break (εmax – how much the material ‘stretches’ before breaking) which 
were similar for both materials (Fig. 1b,c): he properties of the Laser Sintered parts were measured as; polyam-
ide 12 (E = 1590 ± 69 MPa, σuts = 47.3 ± 0.4 MPa, εmax = 31.0 ± 1.2%) and 1.0% B65003 (E = 1580 ± 136 MPa, 
σuts = 47.5 ± 0.4 MPa, εmax = 29.8 ± 3:1%). A 2 sample Welch’s t-test was carried out to compare the materials to 
each other, with p values < 0.05 considered to be signiicantly diferent. he resulting p values were; 0.89 for E, 
0.39 for σuts, and 0.43 for εmax showing that there was no signiicant diference. hese results indicate the materials 
can be used interchangeably, with no efect on the mechanical properties of printed parts.
Part structure and composition. Parts made of the base material and composite were imaged using 
SEM. his revealed the characteristic granular structure of the surface of the Laser Sintered polyamide (Fig. 2). 
Some diferences in contrast were observed between the surface of the base material and the composite (compare 
Fig. 2a,b with Fig. 2c,d) due to the sensitivity to material of backscattered electrons.
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he silver phosphate glass was found to be distributed evenly throughout the parts on this basis of X-Ray 
micro tomography. he diference in electron density between this and the base polyamide 12 led to the silver 
phosphate glass appearing brighter, allowing analysis of its dispersion (Fig. 2e,f).
EDX elemental analysis was used to identify the distribution of the additive on the surface. A spectral analysis 
of both the B65003 additive and the composite part (Table 1), showed that although silver was present in the 
additive, the low concentration was such that it was below the detection limit when combined in the printed part. 
To map the location of the additive (Fig. 3), the elements phosphorus and oxygen were instead used as these were 
abundant in the additive but not in PA2200, as shown in Fig. 3c,d.
Composite parts release silver. Having validated the engineering properties of the parts, we next deter-
mined the extent to which the active antimicrobial, silver, was eluted. his was measured using Inductively 
Coupled Plasma-Optical Emission Spectroscopy (ICP-OES) which detects the concentration of silver ions in 
solution. In a preliminary test, silver phosphate glass was found to release far more silver ions than metallic silver 
powder, further validating this material as an antimicrobial additive (Table 2). We estimate our parts (containing 
1.0% B65003) released a similar amount of silver per unit surface area over 24 hours (~0.012 mg/l/cm2) as a pre-
viously reported compression moulded polyamide 12 composite containing 1.4% Nanosilver (~0.03 mg/l/cm2)23 
released over 100 days. his indicates that our new AM approach yields a material that releases silver (loosely 
speaking) at least as well as existing (non-AM) materials. he surface area of our spheres (used in this calculation) 
was 4.62 ± 0.01 cm2 (standard error, n = 100 {20 parts, 5 measurements per part, pooled}).
Composite parts have an antibacterial effect against gram positive Staphylococcus aureus 
and gram negative Pseudomonas aeruginosa. Assured that our composite parts release silver, we 
then checked for antibacterial activity against two representative pathogens. Parts were incubated in Phosphate 
Bufered Saline (PBS) containing bacteria for 24 hours, ater which the amount of bacteria in the medium (plank-
tonic bacteria) and on the parts surface (bioilm) was measured. Bacteria survived for 24 hours in PBS with a 
normal polyamide 12 part. here were fewer planktonic S. aureus in PBS that had held a part made of the antibac-
terial composite than in the equivalent for polyamide 12, with some samples containing so few bacteria that they 
Figure 1. Engineering properties of parts (a) Photograph of a selection of parts made from PA2200 (let) 
alongside the 1% B65003 composite material (right). (b) Raw stress-strain curves from tensile testing. (c) A 
comparison of Young’s modulus (E), ultimate tensile strength (σuts) and elongation at break (εmax) for both 
materials.
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were undetectable in our assay (Fig. 4a). his efect was mirrored for S. aureus bioilms (Fig. 4b). In the case of P. 
aeruginosa there was also a reduction in numbers of bacteria comparing antibacterial polyamide 12 (containing 
1.0% B65003) to polyamide 12 for both planktonic organisms and those in bioilms on the surface of the parts 
(Fig. 4c,d).
ơǤ To explore whether the 
anti-bioilm properties of our material were mediated by contact between bacteria and parts, we incubated parts 
Figure 2. Images of parts – (a,b) SEM images of base material (sintered PA2200), (c,d) composite material. 
he lighter, more angular objects in d are likely silver phosphate glass. (e) X-Ray micro tomography section of 
base material (PA2200), showing pores. (f) X-Ray micro tomography section of the composite showing even 
distribution of silver phosphate glass particles.
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in PBS, removed them ater 24 hours and then inoculated the PBS with bacteria. here were less bacteria in PBS 
that had contained antibacterial polyamide 12 (containing 1.0% B65003) than that which had held normal poly-
amide 12 (Fig. 4e). his proves that contact between parts and bacteria is not required for an antibacterial efect 
(it does not totally disprove that there may also be some contact mediated efects). We infer from this that silver 
ions are eluted from the antibacterial polyamide 12 (containing 1.0% B65003) in solution and difuse to their 
targets. he anti-bioilm efect is therefore likely a consequence of bacterial mortality (likely prior to adhesion to 
the antibacterial polyamide 12 (containing 1.0% B65003)) rather than an anti-adhesion mechanism.
Sample
Weight percentage ± Standard Deviation (%)
O C P Ti Mg Ca Ag
B65003 63.6 ± 0.4 16.5 ± 0.4 12.6 ± 0.1 0.0 ± 0.0 3.5 ± 0.0 2.9 ± 0.0 0.9 ± 0.1
PA2200 + 1.0% B65003 72.5 ± 0.1 27.1 ± 0.1 0.2 ± 0.0 0.1 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Table 1. Composition of the silver phosphate glass additive (B65003) and the composite part (PA2200 + 1.0% 
B65003) obtained from EDX analysis.
Figure 3. SEM and EDX map of composite PA2200 + B65003 surface. (a) SEM micrograph of the surface 
scanned with EDX. (b–d) Elemental map from EDX analysis of the surface with colour indicating detection of 
the corresponding element.
Sample Mean Standard Error
n samples above 0.002 mg/l 
detection limit (/total)
Silver ion concentration ater 24 hours incubation of silver or silver phosphate 
glass at 2 mg/ml in water
Control (Water) NA 0/4
Silver Powder 0.006 ± 0.0016 mg/l 3/4
B65003 26 ± 2.5 mg/l 4/4
Silver ion concentration ater 24 hours incubation of polyamide 12 or 
antibacterial polyamide 12 (containing 1.0% B65003) spheres in 5 ml water
PA2200 NA 0/3
PA2200 + 1.0% B65003 0.056 ± 0.018 mg/l 3/3
Table 2. ICP-OES measurements of silver concentration.
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Antibacterial effects are diminished in rich media. PBS is reasonably representative of a very 
nutrient-poor (but osmotically stable and close to pH neutral) environment for bacteria, and is most relevant 
to partly hydrated fomite surfaces such as one might ind in a kitchen or bathroom environment, or in some 
clinical or semi-clinical settings. However, we were also interested in the eicacy of our parts in a rich-media 
Figure 4. Comparison of amount of S. aureus (CFU/ml) in PBS surrounding (a), or attached to (b) polyamide 
12 or antibacterial polyamide 12 (containing 1.0% B65003); and comparison of amount of P. aeruginosa (CFU/
ml) in PBS surrounding (c), or attached to (d) polyamide 12 or antibacterial polyamide 12 (containing 1.0% 
B65003). Comparison of amount of S. aureus (CFU/ml) in PBS previously incubated with polyamide 12 or 
antibacterial polyamide 12 (containing 1.0% B65003) (e).
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environment; one containing a complex mix of biologically derived molecules in which bacteria had the nutri-
ents needed to grow and divide. To investigate this we used Brain Heart Infusion (BHI), a commonly used rich 
medium for growing either S. aureus or P. aeruginosa. In this medium there was no diference between bacteria 
grown in media containing either polyamide 12 or antibacterial polyamide 12 (containing 1.0% B65003) for 
either species (Fig. 5a–d).
We hypothesised, informed by previous work21,22, that the diference in performance between PBS and BHI 
was due to the presence of chemicals in BHI that react with silver ions, rendering them unable to perform their 
antibacterial function, particularly molecules with thiol (sulhydryl) functional groups. To test this, we repeated 
our experiments in PBS containing 1 mM reduced glutathione (Fig. 5e,f). We saw no substantial diference in the 
eicacy of parts made of polyamide 12 or antibacterial polyamide 12 (containing 1.0% B65003) in this medium. 
his result, in the context of previous indings, strongly suggests that the presence of confounding chemicals 
explains the relative lack of eicacy in BHI as compared with PBS.
ơǤ For any use case where parts are to come into contact 
with humans or animals, it is important to determine levels of toxicity. his was achieved by incubating parts with 
2D monolayers of human ibroblast cells at the bottom of tissue culture wells. Such cells make up connective tis-
sue, including dermal skin layers, and produce collagen. We found no diference in metabolic activity (measured 
using a Presto Blue assay) between any of the wells containing either no part, a part made from polyamide or 
antibacterial polyamide 12 (containing 1.0% B65003) (Fig. 6).
Conclusions
We have developed an approach for producing Additive Manufactured parts with antibacterial properties for use 
in the Laser Sintering process. he engineering properties of the new composite are indistinguishable from those 
of the standard polyamide 12 base material. he material is most efective in nutrient-poor hydrated environ-
ments (where reactions that interfere with the activity of the silver are less likely) and under these circumstances 
is able to reduce numbers of planktonic bacteria in its surroundings and numbers of bioilm bacteria attached to 
the surface. We have shown that there are no fundamental issues with cytotoxicity.
Eicacy against such diverse bacterial species as S. aureus and P. aeruginosa, in the context of the long history 
of silver as an antimicrobial agent, strongly suggests a spectrum of action against both Gram positive and Gram 
negative bacteria. Additional work would determine the breadth of antimicrobial activity of our material across 
other species, but given our evidence we would expect our material to be efective against further unwanted 
bacteria.
here are a range of potential uses for the material where favourable circumstances are present, including 
those that are intermittently hydrated, in kitchens, bathrooms and on hospital wards. However, a demonstrable 
lack of eicacy in rich BHI media and in PBS containing reduced glutathione should temper expectations of per-
formance in nutrient-rich environments (e.g. in vivo or in the food industry). Future work will include ield trails 
to validate laboratory results in real-world settings.
Methods
Materials. A polyamide 12 based powder was chosen as the base material (PA2200, EOS) for the antimicro-
bial composite. his was chosen as it is widely used in industry, meaning any added functionality could have a 
high impact in a relatively short timescale. A commercially available silver phosphate glass (B65003, BioCote) was 
chosen to create the antimicrobial efect. his material was provided in powder form, with particle size <40 µm 
and with an angular geometry as shown in Fig. 2d. Prior to printing, the powders were mixed for approximately 
100 minutes in a rotary tumbler with 1.0% (by mass) of B65003 added to virgin (unused) PA2200.
Laser sintering. Parts were produced using an EOS Formiga P100 with the standard settings for PA2200. 
he key parameters used for both materials were, laser power 21 W, scan spacing 0.25 mm, and scan speed 2500 
mm/s; as this was an experimental material no additional contour scan was used. Loose powder was removed 
from the parts using compressed air only, to limit the potential sources of contamination.
Mechanical properties. Tensile testing was carried out using a Tinius Olsen 5K with Laser Extensometer, 
in accordance with the methodology in ASTM D638. A type I specimen was used (Fig. 7), with a minimum of 5 
specimens per material; the Young’s Modulus (E), Ultimate Tensile Strength (σuts), and Elongation at Break (εmax) 
were determined to characterise the mechanical properties.
Scanning electron microscopy. Samples were gold sputter-coated, then imaged using a TESCAN VEGA3 
SEM using an accelerating voltage of 15 kV and detecting backscattered electrons.
Energy-dispersive x-ray spectroscopy. Samples were gold sputter-coated and a TESCAN VEGA3 SEM 
with attached Oxford EDX analysis was used. EDX whole area mapping using secondary electron at 15 kV with 
elements detected automatically chosen by the sotware (AZtec, Oxford instruments) based on all elements 
detectable within the sample.
Micro-CT. 5 × 5 mm cylinders were built and scanned using a Skyscan 1172 MicroCT Scanner using the fol-
lowing parameters: pixel size: 4.87 µm, voltage: 40 kV, intensity: 144 µA, total rotation: 180°, rotation step: 0.35°, 
time: 18 minutes, ilter: none.
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Inductively coupled plasma – optical emission spectroscopy. Powders or parts were incubated for 
24 hours at 37 °C with agitation in distilled water. Supernatant was extracted and, for powder samples, was centri-
fuged (15 minutes at 2000 rpm) and iltered (0.2 µm ilter) to remove suspended powder particles. ICP-OES was 
conducted using a Spectro-Ciros-Vision Optical Emission Spectrometer.
Figure 5. (a) comparison of the amount of S. aureus (CFU/ml) in BHI surrounding, or attached to polyamide 
12 or antibacterial polyamide 12 (containing 1.0% B65003), (b) comparison of amount of P. aeruginosa (CFU/
ml) in BHI surrounding, or attached to polyamide 12 or antibacterial polyamide 12 (containing 1.0% B65003), 
(c) comparison of the amount of S. aureus (CFU/ml) in PBS containing 1 mM reduced glutathione surrounding, 
or attached to polyamide 12 or antibacterial polyamide 12 (containing 1.0% B65003).
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Bacterial strains and growth conditions. Bacterial strains used were clinical isolates of Staphylococcus 
aureus (S235) and Pseudomonas aeruginosa (SOM1) from the Charles Cliford Dental Hospital, Sheield24. hese 
were maintained on Brain Heart Infusion (BHI) agar (Sigma-Aldrich) plates at 37 °C. Liquid cultures were in BHI 
broth (Oxoid). Species of bacteria come in a variety of “strains”. We chose to use “clinical isolates” (strains taken 
from infected patients) as opposed to strains sourced from a standard strain collection, as clinical isolates are 
more representative of the types of bacteria that are encountered in the real environment. BHI is a widely used 
medium derived from animal products it has all the nutrients that the bacteria need. As both P. aeruginosa and S. 
aureus are capable of living in a human host, we grew them at body temperature, 37 °C.
Incubation of parts with bacteria. Overnight cultures were diluted to OD600 = 0.01 (this is a proxy meas-
urement for the number of bacteria in a liquid a – typical maximum is 10) in either PBS or BHI. his solution 
(5 ml) was then added to glass universals containing autoclaved test parts and incubated with agitation (so all of 
the test part was equally exposed) at 37 °C for 24 hours.
ƤǤ Parts were washed twice in PBS to release poorly attached bacteria before being vor-
texed for 30 s in 2 ml PBS to release the well attached bioilm.
ƤǤ Bacterial suspensions were serially ten-fold diluted 10:90 µl in 
PBS in 96-well microtitre plates. Each well in the plate then contained a number of bacteria that could be related 
back to the parent concentration. Subsequently, 20 µl of each dilution was spotted onto BHI agar, such that at 
suiciently high dilutions each individual bacterium could form a colony distinguishable from its neighbours, 
before overnight incubation and colony counting. Once bacteria had been counted at the dilution where the 
highest density of colonies could be distinguished, we were then able to calculate the number of bacteria in the 
parent culture using Eq. 1.
= × ×CFU/ml Count 10 50 (1)dilution
he term Colony Forming Units (CFU) is used, as with this method we determine the number of colonies, 
not individual bacteria and in some cases more than one bacterium may be aggregated together in a single CFU.
Figure 6. Comparison of metabolic activity between ibroblast monolayers containing parts, a disc made of 
polyamide 12 or one made of antibacterial polyamide 12 (containing 1.0% B65003). A Kruskal-Wallis test 
indicates no diference between groups.
Figure 7. Dimensions of a type I tensile test specimen according to ASTM D638.
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Eukaryotic cell culture conditions. To obtain human dermal ibroblasts, human skin was obtained anon-
ymously for medical research, with written informed consent, from individuals undergoing elective surgery for 
breast reduction or abdominoplasty. All methods were carried out in accordance with relevant guidelines and 
regulations and all experimental protocols were approved by the NHS Research Ethics Committee (REC), refer-
ence: 15/YH/017.
To isolate primary ibroblasts, dermis from donated skin was minced, then digested by 0.05% collagenase A 
in Dulbecco’s Modiied Eagle’s Medium (DMEM) overnight at 37 °C with 5% CO2. he cell suspension was cen-
trifuged at 400 g and the pellet resuspended in medium (DMEM supplemented with 10% fetal calf serum (FCS), 
0.25 mg.mL−1 glutamine, 0.625 µg.mL−1 amphotericin B, 100 I.U.mL−1 penicillin, and 100 µg.mL−1 streptomy-
cin). Cells were cultured in ibroblast medium in T25 lasks and incubated at 37 °C with 5% CO2. Medium was 
changed every 2 days, and cells were passaged as needed.
ƤǤ Fibroblasts were seeded at 50,000 cells/ml 
in 12 well plates (1 ml/well) and cultured for 24 hours before parts were added. Ater a further 24 hours parts 
were removed and growth media was replaced with the same containing 10% Presto Blue (Invitrogen). his was 
allowed to develop for 40 minutes before readout on a Tecan Ininite 200 plate reader in luorescence mode with 
excitation at 535 nm and emission at 590 nm. he luorescence of the Presto Blue is proportional to the metabolic 
activity of the cells.
Data availability
he datasets generated during and/or analysed during the current study are available from the corresponding 
authors on reasonable request.
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